Yang Tingting, Peng Yuting, Shao Yuting, Pan Dandan, Cheng Qian, Jiang Zhenzhou, Qian Sitong, Li Baojing, Yan Meng, Zhu Xia, Liu Junjie, Wang Tao, Lu Qian, Yin Xiaoxing
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China.
Department of Pharmacy, Xuzhou Oriental Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu 221004, PR China.
Phytomedicine. 2025 Mar;138:156411. doi: 10.1016/j.phymed.2025.156411. Epub 2025 Jan 20.
Renal tubular injury was a significant pathological change of diabetic kidney disease (DKD), and the amelioration of renal tubular injury through mitochondrial function was an important treatment strategy of DKD. Our previous study had revealed that Jujuboside A (Ju A), the main active substance isolated from Semen Ziziphi Spinosae (SZS), could restore renal function of diabetic mice. However, its protective mechanism against DKD remains unclear.
To investigate the effects and the mechanism of Ju A against DKD-associated renal tubular injury.
The anti-apoptotic effect of Ju A and its protection effect on mitochondria dysfunction of renal tubular epithelial cells (RTECs) were examined in high glucose (HG)-cultured HK-2 cells, and in db/db mice. Subsequently, Network Pharmacology analysis, molecular docking, luciferase assay, chromatin immunoprecipitation (ChIP), Yin Yang 1 (YY1) overexpression lentiviral vector and peroxisome proliferator-activated receptor-γ coactlvator-1α (PGC-1α) specific agonist ZLN005 were all used to identify the protective mechanism of Ju A towards DKD-associated mitochondrial dysfunction of RTECs.
Ju A inhibited RTECs apoptosis and ameliorated mitochondria dysfunction of RTECs of diabetic mice, and HG-cultured HK-2 cells. YY1 was the potential target of Ju A against DKD-related mitochondrial dysfunction, and the down-regulation of YY1 induced by Ju A increased PGC-1α promoter activity, leading to the restored mitochondrial function of HG-treated HK-2 cells. Renal tubule specific overexpression of YY1 intercepted the renal protective effect of Ju A on diabetic mice via blocking PGC-1α-mediated restoration of mitochondrial function of RTECs. The in-depth mechanism research revealed that the protective effect of Ju A towards DKD-associated renal tubular injury was linked to the restored mitochondrial function through YY1/PGC-1α signaling, resulting in the inhibited apoptosis of RTECs in diabetic condition via inactivating CytC-mediated Caspase9/Caspase3 signaling.
Ju A through the inhibition of mitochondria-dependent apoptosis alleviated DKD-associated renal tubular injury via YY1/PGC-1α signaling.
肾小管损伤是糖尿病肾病(DKD)的重要病理变化,通过线粒体功能改善肾小管损伤是DKD的重要治疗策略。我们之前的研究表明,从酸枣仁(SZS)中分离出的主要活性物质酸枣仁皂苷A(Ju A)可恢复糖尿病小鼠的肾功能。然而,其对DKD的保护机制仍不清楚。
研究Ju A对DKD相关肾小管损伤的作用及其机制。
在高糖(HG)培养的HK-2细胞和db/db小鼠中检测Ju A的抗凋亡作用及其对肾小管上皮细胞(RTECs)线粒体功能障碍的保护作用。随后,采用网络药理学分析、分子对接、荧光素酶测定、染色质免疫沉淀(ChIP)、阴阳1(YY1)过表达慢病毒载体和过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)特异性激动剂ZLN005来确定Ju A对DKD相关RTECs线粒体功能障碍的保护机制。
Ju A抑制RTECs凋亡,改善糖尿病小鼠和HG培养的HK-2细胞的RTECs线粒体功能障碍。YY1是Ju A对抗DKD相关线粒体功能障碍的潜在靶点,Ju A诱导的YY1下调增加了PGC-1α启动子活性,导致HG处理的HK-2细胞线粒体功能恢复。肾小管特异性过表达YY1通过阻断PGC-1α介导的RTECs线粒体功能恢复,阻断了Ju A对糖尿病小鼠的肾脏保护作用。深入的机制研究表明,Ju A对DKD相关肾小管损伤的保护作用与通过YY1/PGC-1α信号通路恢复线粒体功能有关,通过使细胞色素C(CytC)介导的半胱天冬酶9/半胱天冬酶3信号通路失活,抑制糖尿病状态下RTECs的凋亡。
Ju A通过抑制线粒体依赖性凋亡,经由YY1/PGC-1α信号通路减轻DKD相关肾小管损伤。